- Home
- TIXT vs QURE Comparison
TIXT vs QURE Comparison
Compare TIXT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIXT
- QURE
- Stock Information
- Founded
- TIXT 2005
- QURE 1998
- Country
- TIXT Canada
- QURE Netherlands
- Employees
- TIXT N/A
- QURE N/A
- Industry
- TIXT EDP Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- TIXT Technology
- QURE Health Care
- Exchange
- TIXT Nasdaq
- QURE Nasdaq
- Market Cap
- TIXT 812.7M
- QURE 725.4M
- IPO Year
- TIXT 2021
- QURE 2007
- Fundamental
- Price
- TIXT $3.74
- QURE $14.28
- Analyst Decision
- TIXT Hold
- QURE Strong Buy
- Analyst Count
- TIXT 9
- QURE 10
- Target Price
- TIXT $4.17
- QURE $37.20
- AVG Volume (30 Days)
- TIXT 1.4M
- QURE 1.2M
- Earning Date
- TIXT 08-01-2025
- QURE 07-31-2025
- Dividend Yield
- TIXT N/A
- QURE N/A
- EPS Growth
- TIXT N/A
- QURE N/A
- EPS
- TIXT N/A
- QURE N/A
- Revenue
- TIXT $2,671,000,000.00
- QURE $20,201,000.00
- Revenue This Year
- TIXT $3.61
- QURE N/A
- Revenue Next Year
- TIXT $3.59
- QURE $278.91
- P/E Ratio
- TIXT N/A
- QURE N/A
- Revenue Growth
- TIXT N/A
- QURE 6.30
- 52 Week Low
- TIXT $2.13
- QURE $3.73
- 52 Week High
- TIXT $6.86
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- TIXT 70.11
- QURE 47.07
- Support Level
- TIXT $3.55
- QURE $13.65
- Resistance Level
- TIXT $3.76
- QURE $14.46
- Average True Range (ATR)
- TIXT 0.12
- QURE 0.78
- MACD
- TIXT -0.00
- QURE -0.18
- Stochastic Oscillator
- TIXT 81.03
- QURE 27.21
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.